Total Funding
70
94
Total FundingSeed raised
Growth Score
-1 pts
Heat Score
40 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
3188
precision-immunology techbio
- Gregory Vladimer: Co-founder and CEOPast Role: Exscientia, VP, Translational Research
Robert Sehlke: Co-founder and CTO
About the Company
Graph is a precision immunology techbio that leverages perturbation modeling from primary patient cell samples combined with multi-omics data to deliver transformative targeted therapies and biomarkers for immune-driven diseases. Graph believes that due to an incomplete understanding of complex immune-mediated diseases, millions of people are left
without adequate treatment options - and AI trained with complex disease data can solve this.
